NCT01761110

Pilot Test of a Community-based Buprenorphine Treatment Intervention

Development of a Community-based Buprenorphine Treatment Intervention

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 77 (actual)
• Sponsor: Albert Einstein College of Medicine · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The main goal of this study is to pilot test the community-based buprenorphine treatment (CBBT) intervention, examining buprenorphine treatment initiation, opioid use, and HIV risk behaviors. Two groups of participants will be followed for 60 days, with 3 research visits. One group will be enrolled prior to the CBBT intervention (pre-intervention), and one group after the CBBT intervention (post-intervention). Data sources will include questionnaires, urine toxicology tests, and medical record data. Investigators hypothesize that compared to the participants in the pre-intervention group, participants in the post-intervention group will be more likely to initiate buprenorphine treatment, reduce opioid use, and reduce high-risk HIV risk behaviors.

Conditions

• Opioid Dependence
• Injection Drug Use

Interventions

Type	Name	Description
BEHAVIORAL	Community-based buprenorphine treatment (CBBT) intervention	Community-based buprenorphine treatment (CBBT) intervention consists of three components which are delivered to staff of syringe exchange programs, including: 1) providing buprenorphine education, 2) facilitating access to buprenorphine treatment, and 3) providing support to individuals who initiate buprenorphine treatment.

Timeline

• Start date: 2012-12-01
• Primary completion: 2014-02-01
• Completion: 2014-02-01
• First posted: 2013-01-04
• Last updated: 2018-04-23

Locations

1 site across 1 country: United States